Welcome to our dedicated page for Medirom Healthcare Technologies SEC filings (Ticker: MRM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. MEDIROM files annual reports on Form 20-F and furnishes current and interim information on Form 6-K under the Securities Exchange Act of 1934. These documents offer detailed insight into the company’s relaxation salon operations, digital preventative healthcare activities, luxury beauty segment, and health-tech initiatives.
Form 6-K reports for MEDIROM frequently include press releases and explanatory notes about key corporate events. Recent examples cover the issuance and closing of Third Unsecured Convertible-Type Corporate Bonds with Share Options, including terms such as interest accrual, maturity dates, conversion options into common shares, and redemption provisions. Other 6-K filings furnish interim financial information, major Key Performance Indicators (KPIs), and updates on equity financing rounds at subsidiary MEDIROM MOTHER Labs Inc.
Through these filings, investors can review how MEDIROM structures its capital and financing, including unsecured short-term bank loans, convertible debt, and bond issuances conducted outside the United States under Regulation S. The filings also describe how proceeds are intended to be used for general corporate or financing purposes, subject to the company’s decisions over time.
Segment disclosures embedded in MEDIROM’s interim reports identify the Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty segments, along with revenue categories such as franchisor-owned outlets, franchise revenue, royalty revenue, sublease revenue, staffing service revenue, and other franchise-related income. These details help readers understand how the MEDIROM Group organizes its operations and reports performance across its salon network and health-tech businesses.
On Stock Titan, each newly furnished MEDIROM Form 6-K or other SEC document is made available with AI-powered summaries that highlight the most important points, such as financing terms, segment information, and material corporate announcements. Real-time updates from EDGAR ensure that filings related to topics like convertible bonds, treasury strategies involving digital assets, and subsidiary equity financings are accessible soon after publication. Users can quickly scan AI-generated explanations of lengthy reports, then open the full text for deeper review when needed.
For investors tracking MRM, this filings page is a central resource for reviewing MEDIROM’s official disclosures on capital structure, segment reporting, and material events as presented in its SEC submissions.
Medirom Healthcare Technologies Inc. is issuing third unsecured convertible corporate bonds with share options totaling JPY 400,000,000 to 11 investors through a third-party allotment. The bonds carry a 2.0% annual interest rate from the day after issuance until June 30, 2026, with interest payable in two installments and the principal due on the maturity date, which the company may extend to December 25, 2026. Between December 12, 2025 and June 10, 2026, bondholders may convert bonds into common shares at a conversion price of JPY 343 per share, and the company also has rights to redeem, or repurchase with bondholder consent, before maturity. Medirom expects gross proceeds of JPY 400,000,000 and currently plans to use the funds for general corporate or financing purposes. The bonds are being sold outside the United States under Regulation S and are not registered under U.S. securities laws.
MEDIROM Healthcare Technologies Inc. (MRM) furnished a Form 6-K announcing it issued a press release about the Series A equity financing round of its subsidiary, MEDIROM MOTHER Labs Inc.
The company notes this information is furnished, not filed, and is not incorporated by reference except as specifically provided. The press release is included as Exhibit 99.1.
MEDIROM Healthcare Technologies Inc. announced that its Board of Directors approved adopting cryptocurrency as part of the company’s treasury strategy. The announcement is presented in a press release furnished as Exhibit 99.1 to this Form 6-K. The company states the information is furnished, not deemed “filed” under the Exchange Act, and is not incorporated by reference except as specifically provided.
MEDIROM Healthcare Technologies Inc. furnished a Form 6-K stating it issued a press release. The company announced a milestone of over 10,000 verifications using a new technological device at its wellness salons. The report notes the information is furnished, not deemed “filed,” and is not incorporated by reference except as specifically provided.
Medirom Healthcare Technologies Inc. furnished a Form 6-K for October 2025. The filing provides an interim report for the six months ended June 30, 2025 and related Inline XBRL files.
The company states that this Form 6-K, including its exhibits, is incorporated by reference into its Form F-3 registration statement (File No. 333-290161) and will form part of that registration statement unless superseded by later filings.
Healthcare Technologies Inc. filed a Form 6-K to notify investors that it issued a press release on October 20, 2025. The release announces the company’s major key performance indicators (KPIs) updated for the month of September 2025 and is attached as Exhibit 99.1.
Medirom Healthcare Technologies Inc. submitted a Form 6-K as a foreign private issuer to furnish a press release dated October 9, 2025. The press release relates to the Series A equity financing round of its subsidiary, MEDIROM MOTHER Labs Inc.
The Form 6-K clarifies that the information, including the attached press release as Exhibit 99.1, is being furnished rather than filed for liability purposes under the U.S. securities laws and will only be incorporated into other filings if specifically referenced.
MEDIROM Healthcare Technologies Inc. submitted a Form 6-K as a foreign private issuer to share an operational update. The company states that on September 25, 2025, it is issuing a press release about expanding the number of its relaxation salon locations that are equipped with a new technological device. The details of this expansion and the device itself are provided in the press release attached as Exhibit 99.1.
The company notes that the information in this Form 6-K and its exhibit is being furnished rather than filed, meaning it is not automatically subject to certain liability provisions or incorporated into other securities filings unless specifically referenced.
Healthcare Technologies Inc. submitted a Form 6-K to notify investors that it issued a press release presenting updated major key performance indicators for August 2025. The press release, dated September 24, 2025, is furnished as Exhibit 99.1 and is not treated as filed or automatically incorporated into other securities law filings.
MEDIROM Healthcare Technologies Inc. filed a Form 6-K to share that the Japan Ground Self-Defense Force has adopted its remote health monitoring system “REMONY”, which is powered by the recharge-free smart tracker “MOTHER Bracelet” developed by its subsidiary, MEDIROM MOTHER Labs Inc. The filing notes that further details are provided in a related press release furnished as an exhibit, and clarifies that this information is being furnished rather than filed for securities law purposes.